The above results showed that HDAC inhibitors were highly effective in inhibiting the viability of tumor cells, and consistent with the published work, HDAC inhibitors could stimulate the differentiation of intestinal epithelial cell types (Wang et al., 2017), which verified the reliability of the drug-response signatures based on the transcriptome analysis in this study. The gene discussed is HDAC9; the disease is neoplasm.